BACKGROUND: Essential tremor (ET) is one of the most common neurological diseases. Few prevalence studies have been conducted in South Asia, and none in Bangladesh, one of the most populated countries in the world. We estimated the prevalence of ET in a population-based study in Araihazar, Bangladesh. METHODS: As part of an in-person evaluation in a health outcomes study, each study participant produced 2 handwriting samples, from which ET diagnoses were assigned by 2 independent movement disorder neurologists. RESULTS: The crude prevalence of ET (age ≥18 years) was 19/1,229 [1.5%, 95% confidence interval (CI) = 1.0-2.4], and was similar in men and women. The crude prevalence was 2.5% in participants aged ≥40 years and was one half that (1.3%) among younger participants (<40 years), although the difference did not reach statistical significance (p = 0.18). The age-adjusted prevalence (United States 2000 census) was 2.0% (95% CI = 1.2-2.8). CONCLUSION: The crude prevalence of ET in Araihazar, Bangladesh, was 1.5%. There is 1 other population-based study in a developing country (Turkey) which, like ours, did not restrict enrollment to middle-aged or elderly individuals and did not rely on screening questionnaires; the crude prevalence in the 2 studies is very similar.
BACKGROUND: Essential tremor (ET) is one of the most common neurological diseases. Few prevalence studies have been conducted in South Asia, and none in Bangladesh, one of the most populated countries in the world. We estimated the prevalence of ET in a population-based study in Araihazar, Bangladesh. METHODS: As part of an in-person evaluation in a health outcomes study, each study participant produced 2 handwriting samples, from which ET diagnoses were assigned by 2 independent movement disorder neurologists. RESULTS: The crude prevalence of ET (age ≥18 years) was 19/1,229 [1.5%, 95% confidence interval (CI) = 1.0-2.4], and was similar in men and women. The crude prevalence was 2.5% in participants aged ≥40 years and was one half that (1.3%) among younger participants (<40 years), although the difference did not reach statistical significance (p = 0.18). The age-adjusted prevalence (United States 2000 census) was 2.0% (95% CI = 1.2-2.8). CONCLUSION: The crude prevalence of ET in Araihazar, Bangladesh, was 1.5%. There is 1 other population-based study in a developing country (Turkey) which, like ours, did not restrict enrollment to middle-aged or elderly individuals and did not rely on screening questionnaires; the crude prevalence in the 2 studies is very similar.
Authors: H C Liu; S J Wang; J L Fuh; C Y Liu; K P Lin; C H Lin; P N Wang; K N Lin; H C Wang; H M Chen; R Chang; E B Larson; G S Wu; P Chou; E L Teng Journal: Neuroepidemiology Date: 1997 Impact factor: 3.282
Authors: Faruque Parvez; Yu Chen; Maria Argos; A Z M Iftikhar Hussain; Hassina Momotaj; Ratan Dhar; Alexander van Geen; Joseph H Graziano; Habibul Ahsan Journal: Environ Health Perspect Date: 2006-03 Impact factor: 9.031
Authors: Eina H Eliasen; Monica Ferrer; Shahin Gaini; Elan D Louis; Maria Skaalum Petersen Journal: Neuroepidemiology Date: 2019-03-19 Impact factor: 3.282